Skip to main content
Premium Trial:

Request an Annual Quote

Dennis Langer, Kreatech, Ambion, GE Healthcare, Affymetrix


People in the News

Sirna Therapeutics said this week that Dennis Langer has been appointed to its board of directors.

Langer is currently managing partner at Phoenix IP Ventures, a Philadelphia-based venture capital firm. Prior to this position, he was president, North America, at Indian drugs firm Dr Reddy's Laboratories. Langer has also held positions at GlaxoSmithKline, SmithKline Beecham, and Eli Lilly.

Langer holds an MD from Georgetown University, a JD from Harvard Law School, and a BA in biology from Columbia University, Sirna said.


Products & Services

Kreatech said this week that it has introduced RNA Ampulse Amplification and labeling kits for gene expression analysis.

According to the company, the kits combine Ambion's MessageAmp II aRNA amplification system technology with Kreatech's Universal Linkage system labeling technology.

The kits offer the ULS labeling molecule bound to a choice of fluorescent dye pairs that have been licensed by Kreatech, including the dyes from GE Healthcare, as well as a biotin kit which is ideal for use on Affymetrix's GeneChip, Kreatech said. In addition the RNA Ampulse kit also includes Kreatech's unique Kreapure columns to purify the labeled aRNA which insures effective removal of un-reacted ULS and higher recoveries of sample, the company added.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.